Cyclo3pss Corporation (CYPS)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 9, 2026
Cyclo3pss Revenue
In the fiscal year ending February 28, 2002, Cyclo3pss had annual revenue of $366.01K with 93.95% growth. Cyclo3pss had revenue of $114.99K in the quarter ending February 28, 2002, with 264.15% growth.
Revenue
366.01K
Revenue Growth
+93.95%
P/S Ratio
0.00
Revenue / Employee
91.50K
Employees
4
Market Cap
41.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2002 | 366.01K | 177.30K | 93.95% |
| Feb 28, 2001 | 188.71K | -562.83K | -74.89% |
| Feb 29, 2000 | 751.54K | -80.63K | -9.69% |
| Feb 28, 1999 | 832.17K | -372.94K | -30.95% |
| Feb 28, 1998 | 1.21M | 594.58K | 97.39% |
| Feb 28, 1997 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 1996 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 1995 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Response Genetics | 16.62M |
| Todos Medical | 10.75M |
| HTG Molecular Diagnostics | 6.21M |
| Rosetta Genomics | 2.86M |
| Arrayit | 2.82M |
| Biocept | 1.36M |
| Optigenex | 991.25K |
| Medivolve | 666.14K |